Aquaporin expression and cell volume regulation in the SV40 immortalized rat submandibular acinar cell line.
The amount of aquaporins present and the cellular ability to perform regulatory volume changes are likely to be important for fluid secretions from exocrine glands. In this work these phenomena were studied in an SV40 immortalized rat submandibular acinar cell line. The regulatory cell volume characteristics have not previously been determined in these cells. Cell volume regulation following hyposmotic exposure and aquaporin induction was examined with Coulter counter methodology, radioactive efflux studies, fura-2 fluorescence, and polymerase chain reaction and Western blot techniques. Cell volume regulation was inhibited by the K(+) channel antagonists quinine and BaCl(2) and the Cl(-) channel blocker 5-nitro-2-(3-phenypropylamino)benzoic acid. A concomitant increase in cellular (3)H-taurine release and Ca(2+) concentration was also observed. Chelation of both intra- and extracellular Ca(2+) with EGTA and the Ca(2+) ionophore A23187 did not, however, affect cell volume regulation. Aquaporin 5 (AQP5) mRNA and protein levels were upregulated in hyperosmotic conditions and downregulated upon return to isosmotic solutions, but were reduced by the mitogen-activated ERK-activating kinase (MEK) inhibitor U0126. A 24-h MEK inhibition also diminished hyposmotically induced cell swelling and cell volume regulation. In conclusion, it was determined that regulatory volume changes in this immortalized cell line are due to KCl and taurine efflux. In conditions that increased AQP5 levels, the cells showed a faster cell swelling and a more complete volume recovery following hyposmotic exposure. This response could be overturned by MEK inhibition.
Hansen
Ann-Kristin
AK
Institute of Oral Biology, University of Oslo, Oslo, Norway.
Galtung
Hilde Kanli
HK
D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics*; D051402:Aquaporin 5 / Q000235:genetics* / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002461:Cell Line, Transformed; D048429:Cell Size; D002614:Chelating Agents / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D020935:MAP Kinase Signaling System / Q000502:physiology; D011189:Potassium Chloride / Q000493:pharmacokinetics; D051381:Rats; D013363:Submandibular Gland / Q000166:cytology*; D013654:Taurine / Q000493:pharmacokinetics; D014316:Tritium; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology*
D000952:Antigens, Polyomavirus Transforming; C496040:Aqp5 protein, rat; D051402:Aquaporin 5; D002614:Chelating Agents; D007476:Ionophores; D014316:Tritium; D013654:Taurine; D000001:Calcimycin; D004533:Egtazic Acid; D011189:Potassium Chloride; D002118:Calcium